SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001640455-18-000035
Filing Date
2018-03-08
Accepted
2018-03-08 15:45:26
Documents
6
Effectiveness Date
2018-03-08

Document Format Files

Seq Description Document Type Size
1 S-8 jnce03082018s-8.htm S-8 82280
2 EXHIBIT 5.1 jnce03082018s-8exhibit51.htm EX-5.1 15261
3 EXHIBIT 23.2 jnce03082018s-8exhibit232.htm EX-23.2 2609
4 wh.jpg GRAPHIC 18919
5 wha01.jpg GRAPHIC 18919
6 whfooter.jpg GRAPHIC 186546
  Complete submission text file 0001640455-18-000035.txt   410443
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-223519 | Film No.: 18676306
SIC: 2836 Biological Products, (No Diagnostic Substances)